Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 19, 2026 · Filed Aug 21, 2026
A major shareholder of Aeon Biopharma paid $243K out of pocket for Aeon Biopharma shares. Shares held went up 22% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$243,455
Shares × reported transaction price
$100K–$500K
+21.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
7 days after results of Aug 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $0.1984 on Aug 19, 2026, at its 52-week low, after a 72% drop over the previous 30 trading days
52-week range $0.1984 (Aug 19, 2026) to $1.40 (Oct 16, 2025), 0% of the way up, from 251 adjusted closes. 30 trading days earlier: $0.7005 on Jul 8, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any AEON insider since May 2025. TIMOTHY P. LYNCH's first open-market purchase of AEON in filings since 2023
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +49.9% | +0.5% | +49.4% |
| 30 days | +33.7% | +0.6% | +33.1% |
Past results only. Not a forecast.
Insider filing
Traded Jun 17 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 17 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 17 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.